Exosomes delivering siRNA targeting the oncogene protein Kras (KrasG12D) demonstrated unprecedented tumor regression and promising potential for targeting pancreatic cancer (Zorde Khvalevsky et al., 2013; Kamerkar et al., 2017). Here, KRAS is linked to pancreatic neoplasm.